Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007267 · ClinicalTrials.gov registry record · Phase 2
Psychological Treatments for Scleroderma
A Phase 2 study of Depression and Pain, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
- 1
- Study location
NCT00007267: Completed Phase 2 study of Depression and Pain, sponsored by Johns Hopkins University.
NCT00007267 is a Phase 2 study of Depression and Pain that has completed, run by Johns Hopkins University. The registered enrollment target is 89 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00007267, a Phase 2 study of Depression and Pain, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the effectiveness of two psychological treatment approaches designed to help people who have scleroderma with three important areas of daily living: pain, depression, and distress about changes in appearance. The study will also evaluate the impact of depression on the two psychological treatments. Because psychological approaches requiring a trained professional can be expensive and are often not available to most patients, this study will also look at the effectiveness of a self-help treatment approach.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive behavioral therapy
- BEHAVIORAL Disease/health education
- BEHAVIORAL Self-help cognitive behavioral intervention facilitated by a psychologist
Study Locations (1)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2001-06 |
| Est. Completion | 2006-06 |
| Phase | Phase 2 |
What the finished NCT00007267 record still lists
NCT00007267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower).
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Cognitive behavioral therapy is the first listed.
NCT00007267 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00007267 about?
NCT00007267 is a clinical study titled "Psychological Treatments for Scleroderma". This study will examine the effectiveness of two psychological treatment approaches designed to help people who have scleroderma with three important areas of daily living: pain, depression, and distress about changes in appearance. The study will also evaluate the impact of depression on the two ps...
What is the current status of trial NCT00007267?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2001-06. Estimated completion is 2006-06.
What conditions does trial NCT00007267 study?
This clinical trial studies the following conditions: Depression, Pain, Systemic Sclerosis, Scleroderma.
What interventions are being tested in trial NCT00007267?
The interventions under investigation include: Cognitive behavioral therapy (BEHAVIORAL), Disease/health education (BEHAVIORAL), Self-help cognitive behavioral intervention facilitated by a psychologist (BEHAVIORAL).
Who is sponsoring clinical trial NCT00007267?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00007267 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00007267's enrollment target sits among peer trials
89 361st of 679 higher than 318 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia